Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Non/invasive Recent news which mentions Non/invasive OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre June 20, 2024 Tags Spain Research Painless From PRLog GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer May 17, 2023 Tags Munich Basal Cell Carcinoma Australia From PRLog Latest research shows Australians still not getting annual skin checks with a Health Professional March 01, 2023 Tags Germany Science New South Wales From PRLog London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study September 27, 2022 Tags Painless Research EPIC/Skin From PRLog German skin cancer patients join the EPIC-Skin study July 28, 2022 Tags Skin Cancer Therapy Rostock NMSC therapy From PRLog Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT April 13, 2022 Tags Bavaria Non/melanoma skin cancer Beauty From PRLog EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT March 10, 2022 Tags OncoBeta Basal Cell Carcinoma United States From PRLog OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia December 21, 2021 Tags New South Wales Science Beauty From PRLog South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT® November 16, 2021 Tags Rhenium/188 Johannesburg Research From PRLog Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia July 13, 2021 Tags Beauty Science New South Wales From PRLog Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.